Written question asked by Freddie van Mierlo (Liberal Democrat) on Tuesday, 10 February 2026, in the House of Commons. It was due for an answer on Monday, 23 February 2026 (named day). It was answered by Zubir Ahmed (Labour) on Monday, 23 February 2026 on behalf of the Department of Health and Social Care.
Givinostat
- Question
-
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 19th January to question 105612, to ask what role the Department for Health and Social Care will have in drug price negotiations following the abolishment of NHS England.
- Answer
-
The target operating model for the integration of NHS England operations into the Department has yet to be finalised. However, drug-price negotiations will continue uninterrupted up to and beyond April 2027, when NHS England will cease to exist as a separate entity.
Secondary information
- Type
- Written question
- Reference
- 112551
- Session
- 2024-26
- Related items
- Subjects
- National Institute for Health and Care Excellence Givinostat NHS England
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-02-23 12:26:49 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/112551
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/112551
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/112551